4.4 Article

Fasudil Promotes alpha-Synuclein Clearance in an AAV-Mediated alpha-Synuclein Rat Model of Parkinson's Disease by Autophagy Activation

Related references

Note: Only part of the references are listed.
Article Multidisciplinary Sciences

ROCK inhibitors upregulate the neuroprotective Parkin-mediated mitophagy pathway

Natalia Moskal et al.

NATURE COMMUNICATIONS (2020)

Review Pharmacology & Pharmacy

ROCK inhibition in models of neurodegeneration and its potential for clinical translation

Jan Christoph Koch et al.

PHARMACOLOGY & THERAPEUTICS (2018)

Article Radiology, Nuclear Medicine & Medical Imaging

[18F]FP-(+)-DTBZ PET study in a lactacystin-treated rat model of Parkinson disease

Chi-Chang Weng et al.

ANNALS OF NUCLEAR MEDICINE (2017)

Article Cardiac & Cardiovascular Systems

Rho-Kinase inhibitor fasudil suppresses high glucose-induced H9c2 cell apoptosis through activation of autophagy

Huikuan Gao et al.

CARDIOVASCULAR THERAPEUTICS (2016)

Article Neurosciences

Fasudil attenuates aggregation of α-synuclein in models of Parkinson's disease

Lars Tatenhorst et al.

ACTA NEUROPATHOLOGICA COMMUNICATIONS (2016)

Review Clinical Neurology

Rho Kinase and Dopaminergic Degeneration: A Promising Therapeutic Target for Parkinson's Disease

Jose L. Labandeira-Garcia et al.

NEUROSCIENTIST (2015)

Article Biochemistry & Molecular Biology

Effect of Trehalose on PC12 Cells Overexpressing Wild-Type or A53T Mutant α-synuclein

Dan-Mei Lan et al.

NEUROCHEMICAL RESEARCH (2012)

Article Neurosciences

Rho GTPase regulation of α-synuclein and VMAT2: Implications for pathogenesis of Parkinson's disease

Zhigang Zhou et al.

MOLECULAR AND CELLULAR NEUROSCIENCE (2011)

Article Biochemical Research Methods

Comparison of incremental and accelerating protocols of the rotarod test for the assessment of motor deficits in the 6-OHDA model

Christelle Monville et al.

JOURNAL OF NEUROSCIENCE METHODS (2006)